{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T12:27:48Z","timestamp":1786969668095,"version":"build-2736575974"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Cancer-associated anorexia is common in patients with locally advanced head and neck cancer undergoing radiotherapy and contributes to nutritional decline, reduced treatment tolerance, and psychosocial distress. While megestrol acetate (MA) has been shown to improve appetite in various cancer populations, limited data exist on its impact on caregiver-related outcomes. This study evaluated the short-term effect of low-dose MA on patients\u2019 appetite and caregivers\u2019 eating-related distress.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This prospective, single-arm observational study included 50 adult patients with histologically confirmed locally advanced head and neck squamous cell carcinoma experiencing treatment-related anorexia. Patients received oral MA 160 mg during radiotherapy for 10 days. Appetite was assessed using the Simplified Nutritional Appetite Questionnaire (SNAQ; range 4\u201320), and caregiver distress was evaluated using the Eating Distress Scale (EDS). Baseline and 10-day follow-up scores were compared using paired statistical tests.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Mean SNAQ score increased significantly from 9.76 \u00b1 1.59 at baseline to 14.32 \u00b1 1.47 at follow-up [mean difference 4.56; 95% confidence interval (CI) 3.97\u20135.14; P = 0.001]. EDS scores decreased significantly from 30.32 \u00b1 2.31 to 18.28 \u00b1 4.59 (mean reduction 12.04; 95% CI 10.77\u201313.30; P = 0.001). Appetite improvement was observed despite advanced disease stage and compromised performance status.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Low-dose MA was associated with significant improvement in appetite and reduction in caregiver eating-related distress over a 10-day follow-up period. These findings suggest short-term symptomatic benefit and support the inclusion of caregiver-centered outcomes in supportive oncology research. Larger controlled studies with longer follow-up are warranted to validate these observations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_296_26","type":"journal-article","created":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T08:00:11Z","timestamp":1786780811000},"page":"577-581","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Short-term outcomes of low-dose megestrol acetate on appetite and caregiver distress in advanced head and neck cancer: A prospective single-arm study"],"prefix":"10.4103","volume":"22","author":[{"given":"Muninder","family":"Kumar","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, AIIMS, Bilaspur, Himachal Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hardik","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, AIIMS, Bilaspur, Himachal Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandra S.","family":"Purohit","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, AIIMS, Bilaspur, Himachal Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Thakur","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, AIIMS, Bilaspur, Himachal Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niketa","family":"Thakur","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, AIIMS, Bilaspur, Himachal Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"key":"R1-20260817","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0959-8049(96)00309-7","article-title":"Supportive use of megestrol acetate in patients with head and neck cancer during radio (chemo) therapy","volume":"33","author":"Fietkau","year":"1997","journal-title":"Eur J Cancer"},{"key":"R2-20260817","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1200\/JCO.1996.14.1.135","article-title":"Randomized double-blind placebo-controlled trial of cisplatin and etoposide plus megestrol acetate\/placebo in extensive-stage small-cell lung cancer: A North Central Cancer Treatment Group study","volume":"14","author":"Rowland","year":"1996","journal-title":"J Clin Oncol"},{"key":"R3-20260817","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41392-025-02331-7","article-title":"Cancer cachexia: Molecular basis and therapeutic advances","volume":"11","author":"Tan","year":"2026","journal-title":"Signal Transduct Target Ther"},{"key":"R4-20260817","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/nrc3829","article-title":"Cancer cachexia: Understanding the molecular basis","volume":"14","author":"Argil\u00e9s","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"R5-20260817","doi-asserted-by":"crossref","first-page":"M48","DOI":"10.1093\/gerona\/56.1.M48","article-title":"The correlation of cytokine levels with body weight after megestrol acetate treatment in geriatric patients","volume":"56","author":"Yeh","year":"2001","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"R6-20260817","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/ajcn.70.2.183","article-title":"Geriatric cachexia: The role of cytokines","volume":"70","author":"Yeh","year":"1999","journal-title":"Am J Clin Nutr"},{"issue":"6 Suppl 9","key":"R7-20260817","first-page":"63","article-title":"Weight changes in women with metastatic breast cancer treated with megestrol acetate: A comparison of standard versus high-dose therapy","volume":"17","author":"Cruz","year":"1990","journal-title":"Semin Oncol"},{"key":"R8-20260817","first-page":"2081","article-title":"Effect of megestrol acetate on quality of life in a dose-response trial in women with advanced breast cancer","volume":"11","author":"Kornblith","year":"1993","journal-title":"The Cancer and Leukemia Group B. J Clin Oncol"},{"key":"R9-20260817","first-page":"2","article-title":"Appetite stimulation and weight gain with megestrol acetate","volume":"17","author":"Aisner","year":"1990","journal-title":"Semin Oncol"},{"key":"R10-20260817","doi-asserted-by":"crossref","first-page":"840","DOI":"10.7326\/0003-4819-109-10-840","article-title":"Megestrol acetate for treatment of cachexia associated with human immunodeficiency virus (HIV) infection","volume":"109","author":"von Roenn","year":"1988","journal-title":"Ann Intern Med"},{"key":"R11-20260817","first-page":"43","article-title":"Megestrol acetate in the treatment of advanced post-menopausal breast cancer","volume":"12","author":"Benghiat","year":"1986","journal-title":"Eur J Surg Oncol"},{"key":"R12-20260817","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/jnci\/82.13.1127","article-title":"Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia","volume":"82","author":"Loprinzi","year":"1990","journal-title":"J Natl Cancer Inst"},{"key":"R13-20260817","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1038\/bjc.1996.297","article-title":"Prospective randomised trial of two dose levels of megestrol acetate in the management of anorexia-cachexia syndrome in patients with metastatic cancer","volume":"73","author":"Gebbia","year":"1996","journal-title":"Br J Cancer"},{"key":"R14-20260817","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1200\/JCO.2000.18.15.2930","article-title":"On appetite and its loss","volume":"18","author":"Jatoi","year":"2000","journal-title":"J Clin Oncol"},{"key":"R15-20260817","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1093\/ajcn\/82.5.1074","article-title":"Appetite assessment: Simple appetite questionnaire predicts weight loss in community-dwelling adults and nursing home residents","volume":"82","author":"Wilson","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"R16-20260817","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/jcsm.13133","article-title":"Development and validation of questionnaires for eating-related distress among advanced cancer patients and families","volume":"14","author":"Amano","year":"2023","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R17-20260817","doi-asserted-by":"crossref","first-page":"e000862","DOI":"10.1136\/esmoopen-2020-000862","article-title":"Caring for the caregiver: A systematic review characterizing the experience of caregivers of older adults with advanced cancers","volume":"5","author":"Adashek","year":"2020","journal-title":"ESMO Open"},{"key":"R18-20260817","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: An international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"key":"R19-20260817","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.radonc.2010.02.017","article-title":"Radiotherapy on the neck nodes predicts severe weight loss in patients with early stage laryngeal cancer","volume":"97","author":"Langius","year":"2010","journal-title":"Radiother Oncol"},{"key":"R20-20260817","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1200\/JCO.1993.11.4.762","article-title":"Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and\/or cachexia","volume":"11","author":"Loprinzi","year":"1993","journal-title":"J Clin Oncol"},{"key":"R21-20260817","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejon.2015.06.002","article-title":"Food connections: A qualitative exploratory study of weight- and eating-related distress in families affected by advanced cancer","volume":"20","author":"Hopkinson","year":"2016","journal-title":"Eur J Oncol Nurs"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_296_26","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T12:01:25Z","timestamp":1786968085000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_296_26"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_296_26","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"2026-02-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}